Cargando…

Immunization costs, from evidence to policy: Findings from a nationally representative costing study and policy translation effort in Tanzania

INTRODUCTION: Information on the costs of routine immunization programs is needed for budgeting, planning, and domestic resource mobilization. This information is particularly important for countries such as Tanzania that are preparing to transition out of support from Gavi, the Vaccine Alliance. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaughan, Kelsey, Clarke-Deelder, Emma, Tani, Kassimu, Lyimo, Dafrossa, Mphuru, Alex, Manzi, Fatuma, Schütte, Carl, Ozaltin, Annette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604567/
https://www.ncbi.nlm.nih.gov/pubmed/33077300
http://dx.doi.org/10.1016/j.vaccine.2020.10.004
_version_ 1783604166026854400
author Vaughan, Kelsey
Clarke-Deelder, Emma
Tani, Kassimu
Lyimo, Dafrossa
Mphuru, Alex
Manzi, Fatuma
Schütte, Carl
Ozaltin, Annette
author_facet Vaughan, Kelsey
Clarke-Deelder, Emma
Tani, Kassimu
Lyimo, Dafrossa
Mphuru, Alex
Manzi, Fatuma
Schütte, Carl
Ozaltin, Annette
author_sort Vaughan, Kelsey
collection PubMed
description INTRODUCTION: Information on the costs of routine immunization programs is needed for budgeting, planning, and domestic resource mobilization. This information is particularly important for countries such as Tanzania that are preparing to transition out of support from Gavi, the Vaccine Alliance. This study aimed to estimate the total and unit costs for of child immunization in Tanzania from July 2016 to June 2017 and make this evidence available to key stakeholders. METHODS: We used an ingredients-based approach to collect routine immunization cost data from the facility, district, regional, and national levels. We collected data on the cost of vaccines as well as non-vaccine delivery costs. We estimated total and unit costs from a provider perspective for each level and overall, and examined how costs varied by delivery strategy, geographic area, and facility-level service delivery volume. An evidence-to-policy plan identified key opportunities and stakeholders to target to facilitate the use of results. RESULTS: The total annual economic cost of the immunization program, inclusive of vaccines, was estimated to be US$138 million (95% CI: 133, 144), or $4.32 ($3.72, $4.98) per dose. The delivery costs made up $45 million (38, 52), or $1.38 (1.06, 1.70) per dose. The costs of facility-based delivery were similar in urban and rural areas, but the costs of outreach delivery were higher in rural areas than in urban areas. The facility-level delivery cost per dose decreased with the facility service delivery volume. DISCUSSION: We estimated the costs of the routine immunization program in Tanzania, where no immunization costing study had been conducted for five years. These estimates can inform the program’s budgeting and planning as Tanzania prepares to transition out of Gavi support. Next steps for evidence-to-policy translation have been identified, including technical support requirements for policy advocacy and planning.
format Online
Article
Text
id pubmed-7604567
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Science
record_format MEDLINE/PubMed
spelling pubmed-76045672020-11-10 Immunization costs, from evidence to policy: Findings from a nationally representative costing study and policy translation effort in Tanzania Vaughan, Kelsey Clarke-Deelder, Emma Tani, Kassimu Lyimo, Dafrossa Mphuru, Alex Manzi, Fatuma Schütte, Carl Ozaltin, Annette Vaccine Article INTRODUCTION: Information on the costs of routine immunization programs is needed for budgeting, planning, and domestic resource mobilization. This information is particularly important for countries such as Tanzania that are preparing to transition out of support from Gavi, the Vaccine Alliance. This study aimed to estimate the total and unit costs for of child immunization in Tanzania from July 2016 to June 2017 and make this evidence available to key stakeholders. METHODS: We used an ingredients-based approach to collect routine immunization cost data from the facility, district, regional, and national levels. We collected data on the cost of vaccines as well as non-vaccine delivery costs. We estimated total and unit costs from a provider perspective for each level and overall, and examined how costs varied by delivery strategy, geographic area, and facility-level service delivery volume. An evidence-to-policy plan identified key opportunities and stakeholders to target to facilitate the use of results. RESULTS: The total annual economic cost of the immunization program, inclusive of vaccines, was estimated to be US$138 million (95% CI: 133, 144), or $4.32 ($3.72, $4.98) per dose. The delivery costs made up $45 million (38, 52), or $1.38 (1.06, 1.70) per dose. The costs of facility-based delivery were similar in urban and rural areas, but the costs of outreach delivery were higher in rural areas than in urban areas. The facility-level delivery cost per dose decreased with the facility service delivery volume. DISCUSSION: We estimated the costs of the routine immunization program in Tanzania, where no immunization costing study had been conducted for five years. These estimates can inform the program’s budgeting and planning as Tanzania prepares to transition out of Gavi support. Next steps for evidence-to-policy translation have been identified, including technical support requirements for policy advocacy and planning. Elsevier Science 2020-11-10 /pmc/articles/PMC7604567/ /pubmed/33077300 http://dx.doi.org/10.1016/j.vaccine.2020.10.004 Text en © 2020 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Vaughan, Kelsey
Clarke-Deelder, Emma
Tani, Kassimu
Lyimo, Dafrossa
Mphuru, Alex
Manzi, Fatuma
Schütte, Carl
Ozaltin, Annette
Immunization costs, from evidence to policy: Findings from a nationally representative costing study and policy translation effort in Tanzania
title Immunization costs, from evidence to policy: Findings from a nationally representative costing study and policy translation effort in Tanzania
title_full Immunization costs, from evidence to policy: Findings from a nationally representative costing study and policy translation effort in Tanzania
title_fullStr Immunization costs, from evidence to policy: Findings from a nationally representative costing study and policy translation effort in Tanzania
title_full_unstemmed Immunization costs, from evidence to policy: Findings from a nationally representative costing study and policy translation effort in Tanzania
title_short Immunization costs, from evidence to policy: Findings from a nationally representative costing study and policy translation effort in Tanzania
title_sort immunization costs, from evidence to policy: findings from a nationally representative costing study and policy translation effort in tanzania
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604567/
https://www.ncbi.nlm.nih.gov/pubmed/33077300
http://dx.doi.org/10.1016/j.vaccine.2020.10.004
work_keys_str_mv AT vaughankelsey immunizationcostsfromevidencetopolicyfindingsfromanationallyrepresentativecostingstudyandpolicytranslationeffortintanzania
AT clarkedeelderemma immunizationcostsfromevidencetopolicyfindingsfromanationallyrepresentativecostingstudyandpolicytranslationeffortintanzania
AT tanikassimu immunizationcostsfromevidencetopolicyfindingsfromanationallyrepresentativecostingstudyandpolicytranslationeffortintanzania
AT lyimodafrossa immunizationcostsfromevidencetopolicyfindingsfromanationallyrepresentativecostingstudyandpolicytranslationeffortintanzania
AT mphurualex immunizationcostsfromevidencetopolicyfindingsfromanationallyrepresentativecostingstudyandpolicytranslationeffortintanzania
AT manzifatuma immunizationcostsfromevidencetopolicyfindingsfromanationallyrepresentativecostingstudyandpolicytranslationeffortintanzania
AT schuttecarl immunizationcostsfromevidencetopolicyfindingsfromanationallyrepresentativecostingstudyandpolicytranslationeffortintanzania
AT ozaltinannette immunizationcostsfromevidencetopolicyfindingsfromanationallyrepresentativecostingstudyandpolicytranslationeffortintanzania